4-Hydroxybenzyl cyanide (CAS No 14191-95-8) is a compound of interest in the field of biomedical research particularly in exploring its biochemical pathways and potential therapeutic applications Originating from phenolic derivatives it acts primarily by targeting specific signal transduction pathways though the precise mechanisms are subject to ongoing study In vitro its activity is often observed in the nanomolar to low micromolar range indicating significant potential for cellular impact at low concentrations Common applications include using diverse cell models to evaluate its effects on cellular proliferation and apoptosis as well as in animal studies to explore potential pharmacological benefits Additionally it serves as a candidate in drug screening programs for developing novel therapeutic agents Experimental concentrations typically depend on the specific research design ensuring adaptability across various investigative approaches